Telmisartan: Clinical Trials

27 trials of Telmisartan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 5 terminated, 1 not yet recruiting, 1 recruiting. 27 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 227Completed 19, Terminated 5, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 34Completed 3, Unknown 1
Phase 12Completed 1, Not yet recruiting 1

Follow Telmisartan: new trials by email Literature Review of Telmisartan trials Research Report on Telmisartan

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Telmisartan, Doxorubicin (DOX) - Breast Cancer, Doxorubicin Induced Cardiomyopathy
Phase 1 / Phase 2Not yet recruitingTanta University362026-02-012026-01-29
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
Telmisartan - Ovarian Cancer
Phase 2RecruitingTyler J Curiel332026-01-212026-01-28
Efficacy and Safety of HB-1 for Panic Disorder
HB-1, Telmisartan Only Product in Oral Dose Form, Verapamil Only Product in Oral Dose Form - Panic Disorder, Mental Illness
Phase 2TerminatedHB BioTech, LLC1702024-10-292026-09-24
INvestigating TELmisartin Study
Telmisartan Oral Product, Placebo - Covid19
Phase 2TerminatedUniversity of Hawaii242021-09-012022-07-01
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment
Phase 2 / Phase 3UnknownANRS, Emerging Infectious Diseases6002021-04-122023-01-31
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet, Telmisartan 40Mg Oral Tablet, Atorvastatin 20 Mg Oral Tablet - COVID-19, COVID-19 Drug Treatment
Phase 2 / Phase 3CompletedANRS, Emerging Infectious Diseases2942020-11-272024-12-27
Telmisartan in Respiratory Failure Due to COVID-19
Telmisartan - COVID-19, Respiratory Insufficiency
Phase 2CompletedAbraham Edgar Gracia-Ramos662020-08-122023-10-05
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
Vitamins, Telmisartan, Ciclesonide - Corona Virus Infection, Sars-CoV2
Phase 2 / Phase 3CompletedUniversity Hospital, Bordeaux4122020-07-292026-05-12
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
Telmisartan 40mg, Placebo - COVID-19
Phase 2TerminatedUniversity of Hawaii242020-07-012023-08-21
Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)
Telmisartan tablets - Neuropathic Pain, Chemotherapy Effect
Phase 2CompletedDr. Frank Behrens352020-04-092024-08-28
Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
AD209, Amlodipine low, Amlodipine high - Hypertension,Essential
Phase 2CompletedAddpharma Inc.1762020-02-252021-07-21
Telmisartan Pilot Study on Treatment Resistant Schizophrenia
Telmisartan Pill - Schizophrenia, Schizo Affective Disorder
Phase 2TerminatedXiaoduo Fan62019-02-012022-03-02
Health Evaluation in African Americans Using RAS Therapy
Telmisartan 20mg, Telmisartan 40mg, Placebo - Alzheimer's Disease
Phase 1 / Phase 2CompletedEmory University612015-04-012024-05-23
Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
TDF/3TC/EFV + Telmisartan, TDF/3TC/EFV only - Acute HIV Infection, HIV CNS Involvement
Phase 2CompletedSEARCH Research Foundation212015-01-012019-09-19
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
Perindopril, Telmisartan - Alzheimer's Disease
Phase 2TerminatedSunnybrook Health Sciences Centre232014-03-012025-05-06
Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)
Telmisartan - HIV-1 Infection
Phase 2CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections582014-01-012021-08-03
A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease
Telmisartan - Endothelial Dysfunction
Phase 2CompletedUniversity of California, Los Angeles172012-08-012014-12-08
CKD-828 Primary Hypertension Trial(Dose-selection)
S-Amlodipine, Telmisartan, S-Amlodipine, Telmisartan - Hypertension
Phase 2CompletedChong Kun Dang Pharmaceutical4302010-07-012011-04-26
HIV and Fat Accumulation
Telmisartan - HIV Infection
Phase 2CompletedUniversity of California, Los Angeles352010-05-012019-02-04
Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients
Aliskiren/ Valsartan, Telmisartan/ Ramipril - Hypertension
Phase 2CompletedNovartis Pharmaceuticals882009-07-012016-11-18

Showing 20 of 27. Sign in to see all of them.

Conditions studied

Hypertension (7)  ·  COVID-19 (5)  ·  Alzheimer Disease (2)  ·  Breast Neoplasms (2)  ·  Essential Hypertension (2)  ·  Ovarian Neoplasms (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Coronavirus Infections (1)  ·  Diabetes Mellitus (1)  ·  HIV Infections (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Inflammation (1)

Sponsors

Boehringer Ingelheim (5)  ·  ANRS, Emerging Infectious Diseases (2)  ·  University of California, Los Angeles (2)  ·  University of Hawaii (2)  ·  Abraham Edgar Gracia-Ramos (1)  ·  Addpharma Inc. (1)  ·  Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Dr. Frank Behrens (1)  ·  Emory University (1)  ·  HB BioTech, LLC (1)  ·  Mario Negri Institute for Pharmacological Research (1)  ·  Medical University of Vienna (1)  ·  Novartis Pharmaceuticals (1)  ·  SEARCH Research Foundation (1)

Countries

United States (9)  ·  Canada (2)  ·  Germany (2)  ·  Italy (2)  ·  South Korea (2)  ·  Australia (1)  ·  Austria (1)  ·  Burkina Faso (1)  ·  Côte d’Ivoire (1)  ·  Denmark (1)  ·  Egypt (1)  ·  France (1)  ·  Guinea (1)  ·  Japan (1)  ·  Mexico (1)

Top investigators

Abraham Edgar Gracia-Ramos, MD MSc (1)  ·  Cecilia M Shikuma (1)  ·  Cecilia M Shikuma, MD (1)  ·  ChangGu Park, M.D., Ph.D (1)  ·  Ivy Wilkinson-Ryan, MD (1)  ·  Jordan E. Lake, MD (1)  ·  Jordan E. Lake, MD, MSc (1)  ·  Jordan Lake, M.D. (1)  ·  Krista Lanctot, PhD (1)  ·  Martin Clodi, MD (1)  ·  Martin P Huelsmann, MD (1)  ·  Martin Sebastian, MD (1)

Results publications

PMID 17389151, PMID 23516440, PMID 23810874, PMID 27658740, PMID 33050924, PMID 34473343, PMID 36094783, PMID 36574985, PMID 38454482, PMID 39082471, PMID 39443527

NIH funding

1RF1AG051514 (1), 2008 (1), R01NS084911 (1), U54MD007601 (1), UM1AI068636 (1)